BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Melanoma Institute Australia - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://melanoma.org.au
X-WR-CALDESC:Events for Melanoma Institute Australia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Sydney
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Brisbane
BEGIN:STANDARD
TZOFFSETFROM:+1000
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20260308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20261101T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20270314T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20271107T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Perth
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:AWST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Melbourne
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Tokyo
BEGIN:STANDARD
TZOFFSETFROM:+0900
TZOFFSETTO:+0900
TZNAME:JST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Melbourne
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260522T170000
DTEND;TZID=Australia/Sydney:20260522T170000
DTSTAMP:20260408T012448
CREATED:20260331T014109Z
LAST-MODIFIED:20260331T014109Z
UID:10000271-1779469200-1779469200@melanoma.org.au
SUMMARY:ACRF Annual Research Grants
DESCRIPTION:Australian Cancer Research Foundation (ACRF) awards capital grants (between $1.5 to $5 million) for technology\, equipment and infrastructure for cancer research at Australian medical research institutes\, hospitals and universities. \nGrant applications are open to research into all types of cancer with a research focus on detection\, prevention\, and/or treatment. \nSince 1984\, ACRF has awarded $209.3 million to 93 research grants in 44 Australian cancer research institutes. \nACRF promotes collaboration amongst researchers and clinicians and encourages novel and innovative cancer research projects. All applications are competitively reviewed by the ACRF Medical Research Advisory Committee (MRAC) who recommend the best projects to the ACRF Board of Trustees for funding. \nKey Dates\nApplications close: 5:00pm\, Friday 22 May 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/acrf-annual-research-grants/
CATEGORIES:Grants,Infrastructure & Equipment
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/ACRF_Annual_Grants600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260523
DTEND;VALUE=DATE:20260524
DTSTAMP:20260408T012448
CREATED:20251016T004702Z
LAST-MODIFIED:20251016T004702Z
UID:10000204-1779494400-1779580799@melanoma.org.au
SUMMARY:ASICS Runaway Noosa Marathon 2026
DESCRIPTION:The ASICS Runaway Noosa is excited to return on Saturday 23 May 2026. \nEscape to world famous Noosa for Runaway Noosa Marathon and a weekend filled with good times. With a flat\, fast and friendly multi-lap course set in the heart of Noosa township and multi distances to choose from\, it’s easy to find your happy running place right here. \nOur unique multi-lap course – starting and finishing in the heart of Noosa only steps from Hastings Street – means you’re never far from fellow runners and supporters. \nWhen you nominate MIA as your charity of choice\, funds raised support our life-saving melanoma research\, so we can reach our mission of zero deaths from melanoma. \nMake sure you set up your fundraising page\, as well as registering for the event – both can be done at the link below. \nREGISTER NOW
URL:https://melanoma.org.au/event/asics-runaway-noosa-marathon-2026/
CATEGORIES:Running Events,Fundraiser
ATTACH;FMTTYPE=image/png:https://melanoma.org.au/wp-content/uploads/2022/04/Runaway-Noosa-Marathon.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260529
DTEND;VALUE=DATE:20260601
DTSTAMP:20260408T012448
CREATED:20260129T032424Z
LAST-MODIFIED:20260129T032424Z
UID:10000239-1780012800-1780271999@melanoma.org.au
SUMMARY:IAP 50th Annual Scientific Meeting
DESCRIPTION:The 50th Annual Scientific Meeting of the Australasian Division of the International Academy of Pathology (IAP) will be held from May 29 to May 31\, 2026\, at the Brisbane Convention and Exhibition Centre in Brisbane\, Australia. This event is a significant gathering for pathologists and healthcare professionals\, offering a platform to share advancements\, research findings\, and best practices in the field of pathology. Attendees can expect informative sessions\, networking opportunities\, and the chance to engage with leading experts in the industry. \n​Key Dates \nAbstracts close: 27 February 2026 \nEarly bird registration closes: 10 April 2026 \nMeeting Venue \nBrisbane Convention and Exhibition Centre \nCnr Merivale and Glenelg Streets \nSouth Bank\, Brisbane QLD 4101 AUSTRALIA​ \n​ \nFIND OUT MORE
URL:https://melanoma.org.au/event/iap_asm_2026/
LOCATION:Brisbane Convention and Exhibition Centre\, Cnr Merivale and Glenelg Streets\, South Bank\, Brisbane\, QLD\, 4101\, Australia
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/01/IAP_50_ASM_2026-600-x-338-px-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260529
DTEND;VALUE=DATE:20260603
DTSTAMP:20260408T012448
CREATED:20251201T065545Z
LAST-MODIFIED:20260106T024359Z
UID:10000218-1780012800-1780444799@melanoma.org.au
SUMMARY:2026 ASCO Annual Meeting
DESCRIPTION:#ASCO26 is The Place to Be Inspired \nThe 2026 ASCO (American Society Of Clinical Oncology) Annual Meeting Program will feature over 200 sessions complementing Dr. Eric Small’s Presidential theme\, The Science and Practice of Translation: Improving Cancer Outcomes Worldwide. \nYour all-access pass to the most clinically relevant cancer science. #ASCO26 session highlights include: \n\nPlenary Session\, featuring the meeting’s most practice-changing and clinically relevant abstract presentations and discussions\nOpening Session\, featuring the Presidential Address and Karnofsky Award and Lecture\nASCO Voices\n24 Oral Abstract Sessions\, 24 Rapid Oral Abstract Sessions\, and 13 Clinical Science Symposia\, featuring over 450 oral abstract presentations\n15 Case-Based Panels\, featuring interactive audience polling\nJoint Sessions with AACR\, ASPO\, and ECO\nOver 2\,700 Poster presentations\, including Trials in Progress\n\nLocation: McCormick Place\, Chicago & Online \nKey Dates: \nAbstract Submitter Opens: November 5 2025\nAbstract Submission Deadline: January 27 2026\, at 11:59 PM (ET)\nLate-Breaking Abstract Submission Deadline: March 9 2026\, at 12:00 PM (Noon) (ET)\nAbstract Notification Sent to First Author: March 27 2026\nAbstract Withdrawal Deadline: April 5 2026\nAbstract Titles\, including LBAs\, Released online: April 21 2026\nRegular Abstracts Released on ASCO.org/abstracts: May 21 2026 at 5:00 PM ET \nFIND OUT MORE
URL:https://melanoma.org.au/event/2026-asco-annual-meeting/
LOCATION:McCormick Place Convention Center\, Chicago\, IL\, 60616\, United States
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/png:https://melanoma.org.au/wp-content/uploads/2025/12/2026-ASCO-1-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260529T170000
DTEND;TZID=Australia/Sydney:20260529T170000
DTSTAMP:20260408T012448
CREATED:20260331T013722Z
LAST-MODIFIED:20260401T011603Z
UID:10000273-1780074000-1780074000@melanoma.org.au
SUMMARY:Perpetual Ramaciotti Medal for Excellence in Biomedical Research
DESCRIPTION:The Ramaciotti Medal is an annual award of $50\,000. The Medal honours an individual who has made an outstanding discovery (or discoveries) in clinical or experimental biomedical research that has had an important impact on biomedical science\, clinical science\, or the way in which healthcare is delivered. \nTo be eligible for the Ramaciotti Medal\, the greater part of the nominee’s work leading to the discovery (or discoveries) must have been conducted in Australia and they must still be actively engaged in this work. \nThe applicant must be peer nominated and the final recipient is selected based on a recommendation by the Ramaciotti Foundations Scientific Advisory Committee to Perpetual. Many past winners are highly regarded individuals in the top echelon of the biomedical research industry. \nKey Dates\nApplications close: Friday 29 May 2026\, 5pm AEST\nApplicants advised of outcome: September 2026\nRecipients announced: October 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/perpetual-ramaciotti-medal-for-excellence/
CATEGORIES:Discovery,Grants
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/Ramaciotti_Medal_Perpetual-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260529T170000
DTEND;TZID=Australia/Sydney:20260529T170000
DTSTAMP:20260408T012448
CREATED:20260331T013938Z
LAST-MODIFIED:20260401T011222Z
UID:10000272-1780074000-1780074000@melanoma.org.au
SUMMARY:Perpetual Ramaciotti Health Investment Grants
DESCRIPTION:Ramaciotti Health Investment grants of up to $100\,000 are awarded to individuals in universities\, public hospitals or institutes for a contribution towards the undertaking of health or medical research with the potential path to clinical application within five years. A Health Investment grant is intended to provide enabling research support for an autonomous early career investigator who is taking\, or has recently taken\, a substantive position. \nGrants are awarded by Perpetual\, Trustee of the Foundations\, on the recommendation of a dedicated Scientific Advisory Committee. \nIn 2026 The Ramaciotti NSW Foundation will award up to six grants and The Ramaciotti Australia Foundation up to four grants. The Ramaciotti Australia Foundation supports organisations outside of NSW. \nKey Dates\nApplications close: Friday 29 May 2026\, 5pm AEST\nApplicants advised of outcome: September 2026\nRecipients announced: October 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/perpetual-ramaciotti-health-investment-grants/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/Ramaciotti-Health-Investment-Grants-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260530T170000
DTEND;TZID=Australia/Sydney:20260530T170000
DTSTAMP:20260408T012448
CREATED:20260331T013448Z
LAST-MODIFIED:20260331T013448Z
UID:10000274-1780160400-1780160400@melanoma.org.au
SUMMARY:The Viertel Charitable Foundation Clinical Investigator Awards
DESCRIPTION:Establishment grants for Clinical Investigators have been initiated by the Foundation in order to stimulate and encourage clinical research in Australia. In particular the grants are intended to assist new investigators to establish their research programs at the time of the difficult transition from doctoral and post-doctoral training posts to their first definitive clinical positions in an academic environment. Clinical Investigators are awarded a once only grant of $90\,000. \nEligible applicants will be medical graduates or graduates of other clinical disciplines who have completed both their clinical and research training which will normally be at doctoral level and are commencing their first definitive clinical position\, or have been in such a post for no more than 36 months on 1 May of the year of application. \nApplicants should be actively engaged in clinical work and pursuing health and medical research in a university clinical department\, a teaching hospital\, a clinical research unit of a research institute or in an academic general practice setting. The applications will be judged predominantly on the quality of the applicant’s track record and career achievements to date. The quality of a brief research proposal will also be taken into account. \nKey Dates\nApplications open: 6 April 2026\nApplications close: 30 May 2026 \nThe Guidelines will be available here when the round opens. \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/the-viertel-foundation-investigator-awards/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/The-Viertel-Clinical-Investigator-Awards-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260603T170000
DTEND;TZID=Australia/Sydney:20260603T170000
DTSTAMP:20260408T012448
CREATED:20260331T013308Z
LAST-MODIFIED:20260331T013308Z
UID:10000275-1780506000-1780506000@melanoma.org.au
SUMMARY:NHMRC Postgraduate Scholarships
DESCRIPTION:The National Health and Medical Research Council (NHMRC) Postgraduate Scholarships scheme funds successful applicants to attain a research based postgraduate degree – Doctor of Philosophy (PhD) or a Research Masters Degree. \n\nIt aims to support these outstanding health and medical graduates early in their career so they can be trained to conduct research that is internationally competitive and develop a capacity for original independent research within Australia. \nThe intended outcome of the Postgraduate Scholarships scheme is increased research capacity within Australia. \nPostgraduate Scholarships may be funded by\, or in conjunction with\, other organisations. These grants offer opportunities to researchers whose work is particularly relevant to the priorities and research interests of the partner organisations. \n\nKey Dates\nApplications open: 8 April 2026\nMinimum data due date: 13 May 2026\nApplications close: 3 June 2026\nProposed peer review: July/August 2026 \nThe Guidelines will be available here when the round opens. \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/nhmrc-postgrad-scholarships/
CATEGORIES:Early to Mid Career Researcher,Grants
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/NHMRC-Postgraduate-Scholarships-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260607
DTEND;VALUE=DATE:20260608
DTSTAMP:20260408T012448
CREATED:20251016T010239Z
LAST-MODIFIED:20251016T010239Z
UID:10000205-1780790400-1780876799@melanoma.org.au
SUMMARY:Rosebud Running Festival 2026
DESCRIPTION:The Rosebud Running Festival course will cover sections along the foreshore trails (Bay trial) with runners being able to enjoy running through some stunning landscapes with Port Phillip Bay as the backdrop. The course will take competitors from the Start/Finish line at Rosebud to McCrae and back to Rosebud for the 5km and 10km events. The Marathon (2 Laps) + Half Marathon competitors will continue past the start line at Rosebud and head towards Capel Sound with the turnaround just before the Rye Pier and finish at Rosebud. The weekend features a variety of running & walking events to suit all ages and fitness levels. All finishers receive a finishers medal. \nWhen you nominate MIA as your charity of choice\, funds raised support our life-saving melanoma research\, so we can reach our mission of zero deaths from melanoma. \nMake sure you set up your fundraising page\, as well as registering for the event – both can be done at the link below. \nREGISTER NOW
URL:https://melanoma.org.au/event/rosebud-running-festival-2026/
CATEGORIES:Fundraiser,Running Events
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2025/10/Rosebud-Running-Festival-.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260607
DTEND;VALUE=DATE:20260608
DTSTAMP:20260408T012448
CREATED:20251016T025834Z
LAST-MODIFIED:20251027T235104Z
UID:10000206-1780790400-1780876799@melanoma.org.au
SUMMARY:Brisbane Marathon Festival 2026
DESCRIPTION:The Brisbane Marathon Festival is an annual running event featuring a marathon\, half marathon\, 10 km\, 5 km\, and 2 km race\, attracting thousands of participants. The feeling of crossing that finish line and achieving your goal is like no other\, so take that first step and sign up now! \nWhen you nominate MIA as your charity of choice\, funds raised support our life-saving melanoma research\, so we can reach our mission of zero deaths from melanoma. \nMake sure you set up your fundraising page\, as well as registering for the event – both can be done at the link below. \nREGISTER NOW
URL:https://melanoma.org.au/event/brisbane-marathon-festival-2026/
CATEGORIES:Fundraiser,Running Events
ATTACH;FMTTYPE=image/png:https://melanoma.org.au/wp-content/uploads/2024/10/Brisbane-Marathon-Festival-2025-1200x675-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260617
DTEND;VALUE=DATE:20260620
DTSTAMP:20260408T012448
CREATED:20260331T011919Z
LAST-MODIFIED:20260331T011919Z
UID:10000280-1781654400-1781913599@melanoma.org.au
SUMMARY:CNSA Annual Congress
DESCRIPTION:The Cancer Nurses Society of Australia (CNSA) Annual Congress is the premier national event for cancer nurses\, researchers\, educators\, and leaders in cancer care. Each year\, Congress brings together professionals from across Australia to connect\, share\, and advance cancer nursing practice. \nOver three days\, delegates experience keynote presentations\, interactive workshops\, concurrent sessions\, poster displays\, and networking events designed to inform\, inspire\, and empower. Congress provides a platform to exchange ideas\, explore evidence-based innovations\, and shape the future of cancer care through nursing leadership and advocacy. \nIn 2026\, under the theme Elevate Cancer Nursing: Innovate. Integrate. Educate. Advocate.\, we’ll highlight how nurses are driving change — translating evidence into practice\, leading multidisciplinary collaboration\, and championing equity in cancer care. \nLocation: Perth Convention and Exhibition Centre\, Australia \nKey Dates: 17 – 19 June 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/cnsa-annual-congress/
LOCATION:Perth Convention and Exhibition Centre\, 21 Mounts Bay Rd\, Perth\, WA\, 6000\, Australia
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/CNSA-Congress600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260618
DTEND;VALUE=DATE:20260621
DTSTAMP:20260408T012448
CREATED:20260302T043440Z
LAST-MODIFIED:20260302T043440Z
UID:10000259-1781740800-1781999999@melanoma.org.au
SUMMARY:2026 New Zealand Skin Cancer Summit
DESCRIPTION:The Summit Organising Committee invites you to join the 2026 New Zealand Skin Cancer Summit. This year marks a new chapter — the first Summit under the new name\, Skin Cancer New Zealand\, and the first to address all types of skin cancer\, not just melanoma. \nOur 2026 theme\, “Equity in action: Bridging gaps for skin cancer”\, reflects our commitment to ensuring prevention\, early detection\, treatment\, and support are accessible and equitable for everyone. The programme will feature engaging keynote presentations\, interactive panels and skills-based workshops showcasing innovative research\, practical strategies\, and collaborative approaches. \nBringing together clinicians\, researchers\, educators\, policymakers\, and advocates from across New Zealand and beyond\, the Summit offers a unique opportunity to share knowledge\, strengthen networks\, and set priorities for skin cancer management that will help to reduce the burden of disease and improve outcomes for those affected. \nOptional pre-Summit workshops | 18 June 2026 \n9.00 am – 12.30 pm: Skin Surgery Masterclass \n1.30 pm – 4.30 pm: Advanced Dermoscopy Masterclass \nThese workshops can be booked individually or together with the Summit. Summit registration is not required to sign up for one or both workshops. \nNew Zealand Skin Cancer Summit | 19 – 20 June 2026 \nWith the theme of bridging gaps in skin cancer\, the Summit will aim to shape a coordinated and equitable future for skin cancer care\, foster collaboration\, and share the latest advancements in prevention\, diagnosis\, treatment and research. A dynamic programme packed with internationally recognised experts and sessions on prevention\, diagnosis\, clinical management\, and research\, makes this an event not to be missed. \nLocation: InterContinental Wellington\, Wellington\, NZ \nKey Dates: \nEarly bird registration closes: 31 March 2026\nAbstract Submission deadline: 27 March 2026\nAbstract Outcomes: 17 April 2026\nE-poster Submission deadline: 23 May 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/2026-nz-skin-cancer-summit/
LOCATION:InterContinental Wellington\, 2 Grey Street\, Wellington\, 6011\, New Zealand
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/02/2026-NZ-Skin-Cancer-Summit600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260621
DTEND;VALUE=DATE:20260622
DTSTAMP:20260408T012448
CREATED:20251016T031613Z
LAST-MODIFIED:20251016T031613Z
UID:10000207-1782000000-1782086399@melanoma.org.au
SUMMARY:Hervey Bay Half Marathon Festival 2026
DESCRIPTION:The Hervey Bay Half Marathon Festival offers runners a truly unique coastal experience\, set against the stunning backdrop of Queensland’s Fraser Coast. With sweeping ocean views\, tranquil beaches\, and an inviting esplanade lined with palms and cafés\, participants will be immersed in the laid-back charm and natural beauty of this coastal paradise. \nWhether you’re chasing a personal best or simply soaking up the scenery\, the course makes the perfect setting for all types of runners—from seasoned athletes to first-timers. \nWith a variety of distances on offer — Half Marathon – 21.1km | 10km | 5km run & 5km walk | 2km Fun Run & Walk — there’s something for everyone to experience the excitement of crossing the finish line along Hervey Bay’s iconic foreshore. \nWhen you nominate MIA as your charity of choice\, funds raised support our life-saving melanoma research\, so we can reach our mission of zero deaths from melanoma. \nMake sure you set up your fundraising page\, as well as registering for the event – both can be done at the link below. \nREGISTER NOW
URL:https://melanoma.org.au/event/hervey-bay-half-marathon-festival-2026/
CATEGORIES:Fundraiser,Running Events
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2025/10/Hervey-Bay-Marathon-Festival.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260714
DTEND;VALUE=DATE:20260729
DTSTAMP:20260408T012448
CREATED:20260401T234731Z
LAST-MODIFIED:20260402T000958Z
UID:10000282-1783987200-1785283199@melanoma.org.au
SUMMARY:MPA-MIA Community Webinar Series 2026
DESCRIPTION:Join us for an informative series of three live webinars for patients with melanoma and their carers. \nHosted by Melanoma Patients Australia (MPA) and Melanoma Institute Australia (MIA)\, each week our free webinar will provide you with a rare opportunity to hear from MIA experts and an MPA community member as they focus on a different topic of interest each week. The webinar will conclude with a Q&A panel discussion. \nThe webinars are held every Tuesday evening for three weeks. Please click on the registration link below for each webinar that you’d like to attend. \nNote that the webinars are held from 7pm to 8pm AEST.\nCost: Free \nWebinar One: ‘Your melanoma nurse: What they do and how they help’ \nWhen: Tuesday 14 July | 7 – 8pm AEST \nSpeakers: \n\nRebecca Johnson – National Melanoma Nurses Program Manager\nPeta Holly – Melanoma Telehealth Nurse Manager\nA Melanoma Patients Australia Community member\n\nREGISTERWebinar Two: ‘Understanding endocrine side effects of immunotherapy’\nWhen: Tuesday 21 July | 7 – 8pm AEST \nSpeakers: \n\nDr Stephanie Zunder – Medical Oncologist\nDr Annabel Hayes – Endocrinologist\nAled Gaynor – Medical Oncology Clinical Nurse Consultant\nA Melanoma Patients Australia Community member\n\nREGISTERWebinar Three: ‘Understanding sentinel lymph node biopsies: Helping you decide’ \nWhen: Tuesday 21 July | 7 – 8pm AEST \nSpeakers: \n\nA/Prof Alexander van Akkooi – Surgical Oncologist\nShahn Coburn – Surgical Clinical Nurse Consultant\nA Melanoma Patients Australia Community member\n\nREGISTER
URL:https://melanoma.org.au/event/mpa-mia-community-webinar-series-2026/
CATEGORIES:Patient Education,Education
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/04/MIAE0367-MIA-_-MPA_WEB-BANNER_1200x675-series.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260723
DTEND;VALUE=DATE:20260726
DTSTAMP:20260408T012448
CREATED:20260331T012303Z
LAST-MODIFIED:20260331T012303Z
UID:10000278-1784764800-1785023999@melanoma.org.au
SUMMARY:ASDR Annual Scientific Meeting
DESCRIPTION:The Australasian Society for Dermatology Research (ASDR) is pleased to invite you to the ASDR 2026 Annual Scientific Meeting\, to be held in person from 23–25 July 2026 at the Westmead Innovation Centre\, Sydney\, Australia. The meeting will deliver a comprehensive scientific program featuring leading national and international experts\, highlighting recent progress and emerging directions in dermatology research. Key areas to be explored include: \n\nKeratinocyte and Squamous Cell Carcinomas\nMelanocyte/ Keratinocyte biology\nMicroenvironment\nFundamental Skin Research\nSkin immunology and immune disorders\nAutoimmune Disorders\nWound Healing and Stem Cells\nMelanoma and Pigmentation Disorders\nSkin Translational Research\n\nWe look forward to bringing together researchers\, clinicians\, and industry leaders to foster collaboration and discussion on the most innovative topics in dermatology research. \nLocation: Westmead Innovation Centre\, Sydney\, Australia \nKey Dates: \nAbstract Submission Deadline: 19 April 2026\nAbstract Outcomes: 15 May 2026\nEarly Bird Registration Deadline: 30 June 2026 at 23:59 AEST\nRegistration Deadline: 16 July 2026 at 23:59 AEST \nFIND OUT MORE
URL:https://melanoma.org.au/event/asdr-annual-meeting/
LOCATION:Westmead Innovation Centre\, Hawkesbury Rd\, Sydney\, NSW\, 2145\, Australia
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/ASDR-ASM-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260724
DTEND;VALUE=DATE:20260726
DTSTAMP:20260408T012448
CREATED:20260129T022216Z
LAST-MODIFIED:20260129T023350Z
UID:10000238-1784851200-1785023999@melanoma.org.au
SUMMARY:Plastic Surgery Congress 2026
DESCRIPTION:Australian Society of Plastic Surgeons welcomes you to the 2026 Plastic Surgery Congress (PSC)\, where the future of plastic\, reconstructive\, and aesthetic surgery takes centre stage. \n​Taking place at the Sofitel Brisbane Central\, PSC 2026 promises a dynamic program packed with cutting-edge content\, world-class presentations\, and the latest global best practices. With two full days of medical education\, hands-on workshops\, and lively social events\, the Congress is designed to spark collaboration and professional growth. \n​In 2026\, delegates can expect an exceptional line-up of international and local faculty\, carefully curated to provide a truly bespoke educational experience. We have introduced a refreshed academic focus\, featuring topics not previously explored in depth at past congresses. These include burns\, peroneal reconstruction\, hands and brachial plexus surgery\, and aesthetics. And of course\, no congress held in Brisbane would be complete without a dedicated emphasis on skin cancer. \n​Expect an exceptional line-up of international and local experts who will showcase ground-breaking techniques and transformative ideas shaping the field today. \n​Key Dates \nAbstracts close: 9 February 2026 \nEarly bird registration closes: 22 April 2026 \nCongress Venue \nSofitel Brisbane Central \n249 Turbot Street Brisbane QLD 4000 AUSTRALIA​ \n​ \nFIND OUT MORE
URL:https://melanoma.org.au/event/psc_2026/
LOCATION:Sofitel Brisbane Central\, 249 Turbot Street\, Brisbane\, QLD\, 4000\, Australia
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/01/PSC_2026-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260805
DTEND;VALUE=DATE:20260808
DTSTAMP:20260408T012448
CREATED:20260331T012114Z
LAST-MODIFIED:20260331T012114Z
UID:10000279-1785888000-1786147199@melanoma.org.au
SUMMARY:MOGA Annual Scientific Meeting
DESCRIPTION:The 2026 MOGA Annual Scientific Meeting (ASM) will bring together Australian medical oncologists to reflect on a timely theme: \nReimagining Cancer Care: Is Less Doing More? \nIn recent years\, oncology has found itself at a fascinating crossroads. With ever-deepening insights into tumour biology\, immunotherapy\, molecular profiling\, and patient-centred care\, we are beginning to ask a powerful and\, at times\, uncomfortable question: Are we sometimes doing too much? \nWe are now confronting the possibility that treatment de-escalation is not just a compromise\, but potentially a pathway to more humane\, precise\, and effective care. This conversation extends well beyond protocols and guidelines. It challenges us to think deeply about patient autonomy\, shared decision-making\, and what quality of life truly means in the era of personalised medicine. \nThis ASM will bridge disciplines and perspectives—from surgical oncology to medical and radiation oncology\, to palliative care and psychosocial support. We will consider not only clinical evidence\, but also the ethical\, logistical\, and emotional dimensions of doing less. We will look at emerging biomarkers and novel drug targets that allow us to fine-tune therapy like never before. Exploring what it means to personalise care in the truest sense—not just through science\, but through listening. \nLocation: RACV Royal Pines\, Gold Coast\, Australia \nKey Dates: \nEarly Bird Registrations Close: 14 June 2026\nAbstract Submissions Close: 14 June 2026\nAbstract Selection Advice: 3 July 2026\nAbstract Acceptance by Presenter: 10 July 2026\nTravel Award Applications Open: 3 July 2026\nTravel Award Applications Close: 10 July 2026\nTravel Award Recipient Notification: 17 July 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/moga-annual-scientific-meeting/
LOCATION:RACV Royal Pines Resort\, Ross Street\, Gold Coast\, Queensland\, 4217\, Australia
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/MOGA-Asm-600-x-338-px-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260830
DTEND;VALUE=DATE:20260831
DTSTAMP:20260408T012448
CREATED:20251016T032249Z
LAST-MODIFIED:20251024T040143Z
UID:10000208-1788048000-1788134399@melanoma.org.au
SUMMARY:2026 TCS Sydney Marathon presented by ASICS
DESCRIPTION:Whether you’re chasing your debut or your next star\, the TCS Sydney Marathon presented by ASICS is your moment to shine. \nSydney is the bucket-list race that redefines what’s possible\, so come experience the place where the world comes to finish. \nWhen you nominate MIA as your charity of choice\, funds raised support our life-saving melanoma research\, so we can reach our mission of zero deaths from melanoma. \nMake sure you set up your fundraising page\, as well as registering for the event – both can be done at the link below. \nREGISTER NOW
URL:https://melanoma.org.au/event/2026-tcs-sydney-marathon-presented-by-asics/
CATEGORIES:Fundraiser,Running Events
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2025/06/TCS-Sydney-Marathon-2025.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260912
DTEND;VALUE=DATE:20260917
DTSTAMP:20260408T012448
CREATED:20260331T012815Z
LAST-MODIFIED:20260331T012815Z
UID:10000256-1789171200-1789603199@melanoma.org.au
SUMMARY:European Congress of Pathology
DESCRIPTION:The European Society of Pathology (ESP) and the Swedish Society of Pathology are delighted to invite you to the 38th European Congress of Pathology (ECP 2026)\, to be held at Stockholmsmässan\, from 12 –16 September 2026\, in the heart of Sweden’s capital. \nECP 2026 will bring together more than 5\,000 participants from all over the world—pathologists\, clinicians\, researchers\, molecular biologists\, bioinformaticians\, medical scientists\, and industry partners. The meeting will provide an ideal opportunity for professional development\, networking\, to exchange insights\, and will demonstrate the commitment of the ESP to contributing to Pathology progress in the near future. \nThe motto of the congress – “Innovation Driving Excellence in Pathology” –acknowledges the significant improvement that pathology innovation has brought and continues to bring to diagnostics\, assessment of prognosis and therapy response prediction and clinical practice. The excellent programme prepared by the ESP working groups\, ESP-affiliated societies\, education and trainee committees\, and other collaborating societies will include keynote lectures\, slide seminars\, symposia\, and interactive workshops\, from internationally renowned speakers and leaders in their fields. There will be a special focus on digital pathology\, AI integration\, and emerging technologies that are transforming our field. \nLocation: Stockholmsmässan\, Stockholm\, Sweden \nKey Dates: \nAbstract submission deadline: 8 April 2026\nAbstract notifications: early June 2026\nRegistration and payment deadline for authors of accepted abstracts: 25 June 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/european-congress-of-pathology/
LOCATION:Stockholmsmässan\, Mässvägen 1\, Älvsjö\, 12530\, Sweden
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/ECP-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261008
DTEND;VALUE=DATE:20261014
DTSTAMP:20260408T012448
CREATED:20260331T012601Z
LAST-MODIFIED:20260331T012601Z
UID:10000277-1791417600-1791935999@melanoma.org.au
SUMMARY:IAP Congress
DESCRIPTION:It is with great pleasure that we welcome you to the 2026 XXXVI Congress of the International Academy of Pathology in Fukuoka\, bringing together the most enthusiastic and dedicated scholars in the field of pathology. Our goal is to create a unique platform where the latest advancements\, challenges\, and debates in diagnostic and molecular pathology are shared and discussed. \nThis biennial international congress on pathology will be held jointly with the 72nd Autumn Annual Meeting of the Japanese Society of Pathology\, which is held annually in Japan. \nAs the theme of this year’s congress is “Vision for the Future”\, we would like to hold a joint session in the sense of a new challenge that is not bound by the conventional format for the continued development of IAP. Key topics in molecular pathology including spatial transcriptome analysis and artificial intelligence will be explored across various subspecialties\, reflecting the evolving landscape of our field. We will also provide the programs on basic issues in pathology such as the educational system and infectious diseases. \nLocation: Fukuoka International Congress Center\, Fukuoka Sunpalace\, Fukuoka\, Japan \nKey Dates: \nAbstract Submission Deadline: Friday 10 April 2026\, 17:00 (JST)\nYoung Pathologist Award Application & Abstract Submission: Friday 10 April 2026\, 17:00 (JST)\nIAP Bursary Abstract Submission: Friday 10 April 2026\, 17:00 (JST)\nIAP Bursary Application Deadline: Thursday 30 April 2026\nNotification of Acceptance: June 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/iap-congress/
LOCATION:Fukuoka International Congress Center\, 2-1 Sekijōmachi\, Fukuoka\, 8120032\, Japan
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/IAP-2026-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261023
DTEND;VALUE=DATE:20261028
DTSTAMP:20260408T012449
CREATED:20260302T035935Z
LAST-MODIFIED:20260302T035935Z
UID:10000257-1792713600-1793145599@melanoma.org.au
SUMMARY:ESMO Congress
DESCRIPTION:The ESMO Congress is a highly influential global oncology meeting for clinicians\, researchers\, patient advocates\, journalists and healthcare industry representatives from all over the world. \nESMO 2026 will be a platform for breakthroughs in oncology research\, clinical practice and patient care. Participants can expect impactful new data\, interactive education\, excellent networking opportunities and an innovative exhibition area. By attending the ESMO Congress 2026\, oncologists will not only gain insights into the latest developments but also play an active role in shaping the future of oncology on a global scale. \nA comprehensive educational and scientific programme will foster the exchange and debate of translational cancer science\, highlight the first announcements of potentially practice-changing data\, and stimulate multidisciplinary discussions aimed at improving treatment options for patients. \nLearning objectives: \n\nTo stay informed about current approaches in cancer prevention\, screening\, and early detection\nTo gain insights into the latest advances in basic\, translational\, and clinical cancer research\nTo explore the clinical implications of scientific breakthroughs in cancer biology\, diagnostics\, and treatment\nTo be updated on state-of-the-art therapeutic strategies for patients with cancer\nTo examine the emerging role of artificial intelligence in cancer diagnosis\, research and therapy\n\nLocation: IFEMA Madrid\, Madrid\, Spain \nKey Dates: \nEarly Registration Deadline: 22 July 2026 at 23:59 CEST\nAbstract Submission Deadline: 12 May 2026 at 21:00 CEST\nLate-Breaking Abstract Submission Deadline: 8 September 2026 at 21:00 CEST\nConference Dates: 23 October 2026 – 27 October 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/esmo-congress/
LOCATION:IFEMA Madrid\, Avda. Del Partenon\, 5\, Madrid\, 28042\, Spain
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/02/ESMO_2026-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261111
DTEND;VALUE=DATE:20261114
DTSTAMP:20260408T012449
CREATED:20260331T011646Z
LAST-MODIFIED:20260331T011646Z
UID:10000281-1794355200-1794614399@melanoma.org.au
SUMMARY:COSA Annual Scientific Meeting
DESCRIPTION:We are honoured to co-convene the 2026 COSA Annual Scientific Meeting (ASM) to be held at the International Convention Centre (ICC) Sydney from Wednesday 11 to Friday 13 November 2026\, with pre-conference workshops being held on Tuesday 10 November. \nThe theme for the 2026 COSA ASM is The precision generation: From cancer prevention to personalised care. \n\n\n\n\n\n\n\n\n\n\nThis theme reflects how far cancer care has evolved; from a one-size-fits-all rigid approach\, to care that is increasingly tailored to the individual\, across the entire cancer journey. \nThe disease theme will have a strong focus on lung cancers\, alongside sessions addressing head and neck cancers\, early-onset cancers such as colorectal cancer\, and brain cancer\, including both primary and metastatic disease. As always\, equity will be embedded throughout the program\, reflecting COSA’s ongoing commitment to improving outcomes for all people affected by cancer. \nIt has been almost a decade since the COSA ASM was held in Sydney\, so we are excited to bring it back to showcase the remarkable advances that have transformed cancer care over this time\, including the molecular biomarker realm and the evolution of novel transformative therapeutics. \nAustralia has developed deep expertise across clinical care\, research and clinical trials\, implementation and policy\, and the program will highlight this local leadership alongside contributions from international experts in the fields of drug development\, precision oncology\, pharmacogenomics and palliative and supportive care. \n\n\n\n\n\nLocation: International Convention Centre (ICC)\, Sydney\, Australia \nKey Dates: \nDelegate Designed Symposia Submissions Close: 3 July 2026\nAbstract Submissions Close: 7 August 2026\nAbstract Decision Notification: 2 September 2026\nAbstract Acceptance by Presenter: 11 September 2026\nEarly Bird Registration Deadline: 11 September 2026\nPre-conference Workshops: 10 November 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/cosa-scientific-meeting/
LOCATION:ICC Sydney and Cockle Bay – Darling Harbour\, 14 Darling Dr\, Sydney\, NSW\, 2000\, Australia
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/Cosa-Asm-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20261111T170000
DTEND;TZID=Australia/Sydney:20261111T170000
DTSTAMP:20260408T012449
CREATED:20260331T013110Z
LAST-MODIFIED:20260331T013110Z
UID:10000276-1794416400-1794416400@melanoma.org.au
SUMMARY:NHMRC Partnership Projects
DESCRIPTION:The Partnership Project funding scheme provides funding and support to create new opportunities for researchers and policy makers to work together to define research questions\, undertake research\, interpret the findings and implement the findings into policy and practice. \n\nPartnership Projects create partnerships among decision makers\, policy makers\, managers\, clinicians and researchers and answer a specific research question to influence health and wellbeing through changes in the delivery\, organisation\, funding and access to health services. \nPartnership Projects will support collaborations\, within the Australian context\, that translate research evidence into health policy and health practice\, to improve health services and processes. \nThe objectives of the Partnership Project scheme are to: \n• Meet the need for more effective integration of research evidence into health policy and service delivery\n• Create partnerships among policy makers\, managers\, service providers and researchers\n• Provide support to answer often complex and difficult questions that policy makers\, managers and service providers face when making decisions and implementing policies that affect Australians’ health and health care\n• Be highly responsive to the priorities of government\, the community and health professionals\n• Enable applicants to apply for funding at any time during the year to allow researchers and Partner Organisations to develop timely collaborations. \n\nKey Dates for Peer Review Cycle 2:\nApplications open: 19 March 2026\nNHMRC-approved Administering Institutions waiver due: 8 July 2026\nMinimum data due: 22 July 2026\nApplications close: 5 August 2026\nPeer review meetings: 17-19 November 2026 \nKey Dates for Peer Review Cycle 3:\nApplications open: 23 July 2026\nNHMRC-approved Administering Institutions waiver due: 14 October 2026\nMinimum data due: 28 October 2026\nApplications close: 11 November 2026\nPeer review meetings: 2-4 March 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/nhmrc-partnership-projects/
CATEGORIES:Industry,Grants
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/NHMRC-Partnership-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261119
DTEND;VALUE=DATE:20261122
DTSTAMP:20260408T012449
CREATED:20260302T042655Z
LAST-MODIFIED:20260302T042655Z
UID:10000258-1795046400-1795305599@melanoma.org.au
SUMMARY:Australasian Melanoma Conference
DESCRIPTION:The Australasian Melanoma Conference 2026 is a premier event for professionals involved in melanoma and skin cancer research\, diagnosis\, and clinical management. The conference will present new discoveries from basic science and explore cutting-edge paradigms in melanoma and skin cancer care. It is designed for clinicians\, researchers\, and healthcare professionals seeking the latest updates in the field and opportunities for networking and collaboration. \nThe AMC 2026 conference program will feature a broad range of speakers across multi disciplines and concurrent sessions under the key categories of: \n\nPrevention\nEarly Detection\nAdvanced Diseases\nSurvivorship\n\nLocation: Sofitel Melbourne on Collins\, Melbourne\, Australia \nKey Dates: \nConference Dates: 19 November 2026 – 21 November 2026\nEarly Bird Registration Deadline: 31 July 2026\nAbstract Submission Deadline: 17 April 2026 at 11:59 PM (AEST) \nFIND OUT MORE
URL:https://melanoma.org.au/event/amc-2026/
LOCATION:Sofitel Melbourne on Collins\, 25 Collins Street\, Melbourne\, Victoria\, 3000\, Australia
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/02/AMC-2026-600-x-338-px.jpg
END:VEVENT
END:VCALENDAR